Augmentation of cGMP signaling has been proposed as a therapeutic strategy for heart failure with preserved ejection fraction (HFpEF)41, and this might be achieved through phosphodiesterase (PDE) inhibition42,43 or administration of nitrate/NO-mimetics44,45. The gene discussed is ALDH7A1; the disease is heart failure.